Literature DB >> 28041919

Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.

Ehud Mekori-Domachevsky1, Yael Guri1, James Yi2, Omri Weisman1, Monica E Calkins3, Sunny X Tang3, Raz Gross4, Donna M McDonald-McGinn5, Beverly S Emanuel5, Elaine H Zackai5, Gil Zalsman6, Abraham Weizman7, Ruben C Gur3, Raquel E Gur2, Doron Gothelf8.   

Abstract

About one third of individuals with 22q11.2 deletion syndrome (22q11.2DS) develop schizophrenia. Notably, a full-blown psychotic disorder is usually preceded by subthreshold symptoms. Therefore, it is important to identify early signs of psychosis in this population, a task that is complicated by the intellectual disabilities typically seen in 22q11.2DS. We aimed to identify subthreshold psychotic symptoms that distinguish 22q11.2DS from other neurodevelopmental disorders. The study included two independent cohorts from Tel Aviv and Philadelphia. 22q11.2DS (N=171) and typically developing (TD; N=832) individuals were enrolled at both sites and further compared to two groups with intellectual disabilities: Williams syndrome (WS; N=21) in the Tel Aviv cohort and idiopathic developmental disabilities (IDD; N=129) in the Philadelphia cohort. Participants and their primary caregivers were interviewed with the Structured Interview for Prodromal Symptoms (SIPS) and psychopathologies were assessed using standardized tools; general cognitive abilities were assessed with the Computerized Neurocognitive Battery. Negative/disorganized subthreshold syndrome was significantly more common in the 22q11.2DS group than in the WS (OR=3.90, 95% CI=1.34-11.34) or IDD (OR=5.05, 95% CI=3.01-10.08) groups. The 22q11.2DS group had higher scores than the two intellectual disabilities groups on several SIPS negative items, including avolition and decreased expression of emotion. Overall, there were few significant correlations between level of cognitive deficits and severity of negative symptoms in 22q11.2DS and only in the Tel Aviv cohort. Our findings suggest that 22q11.2DS individuals at the age of risk for developing psychosis should be closely monitored for negative symptoms.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computerized Neurocognitive Battery (CNB); Negative symptoms; Structured Interview for Prodromal Symptoms (SIPS); Velocardiofacial syndrome; Williams syndrome

Mesh:

Year:  2016        PMID: 28041919      PMCID: PMC5496790          DOI: 10.1016/j.schres.2016.12.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  29 in total

1.  Clinician's judgments of mental health.

Authors:  L LUBORSKY
Journal:  Arch Gen Psychiatry       Date:  1962-12

2.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

3.  Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome.

Authors:  Maude Schneider; Martial Van der Linden; Bronwyn Glaser; Eleonora Rizzi; Sophie P Dahoun; Christine Hinard; Lucia Bartoloni; Stylianos E Antonarakis; Martin Debbané; Stephan Eliez
Journal:  Psychiatry Res       Date:  2012-02-27       Impact factor: 3.222

4.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

5.  A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population.

Authors:  Hiroyuki Kobayashi; Takahiro Nemoto; Hiroki Koshikawa; Yasunori Osono; Ryoko Yamazawa; Masaaki Murakami; Haruo Kashima; Masafumi Mizuno
Journal:  Schizophr Res       Date:  2008-09-21       Impact factor: 4.939

6.  Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.

Authors:  R E Gur; J J Yi; D M McDonald-McGinn; S X Tang; M E Calkins; D Whinna; M C Souders; A Savitt; E H Zackai; P J Moberg; B S Emanuel; R C Gur
Journal:  Mol Psychiatry       Date:  2014-01-21       Impact factor: 15.992

7.  The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort.

Authors:  Monica E Calkins; Tyler M Moore; Kathleen R Merikangas; Marcy Burstein; Theodore D Satterthwaite; Warren B Bilker; Kosha Ruparel; Rosetta Chiavacci; Daniel H Wolf; Frank Mentch; Haijun Qiu; John J Connolly; Patrick A Sleiman; Hakon Hakonarson; Ruben C Gur; Raquel E Gur
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

8.  Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.

Authors:  James J Yi; Ronnie Weinberger; Tyler M Moore; Monica E Calkins; Yael Guri; Donna M McDonald-McGinn; Elaine H Zackai; Beverly S Emanuel; Raquel E Gur; Doron Gothelf; Ruben C Gur
Journal:  Brain Cogn       Date:  2016-05-17       Impact factor: 2.310

9.  Neurocognitive growth charting in psychosis spectrum youths.

Authors:  Ruben C Gur; Monica E Calkins; Theodore D Satterthwaite; Kosha Ruparel; Warren B Bilker; Tyler M Moore; Adam P Savitt; Hakon Hakonarson; Raquel E Gur
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

10.  Prevalence estimation of Williams syndrome.

Authors:  Petter Strømme; Per G Bjørnstad; Kjersti Ramstad
Journal:  J Child Neurol       Date:  2002-04       Impact factor: 1.987

View more
  6 in total

1.  Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.

Authors:  Omri Weisman; Yael Guri; Raquel E Gur; Donna M McDonald-McGinn; Monica E Calkins; Sunny X Tang; Beverly Emanuel; Elaine H Zackai; Stephan Eliez; Maude Schneider; Marie Schaer; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Vandana Shashi; Stephen R Hooper; Marco Armando; Stefano Vicari; Maria Pontillo; Leila Kushan; Maria Jalbrzikowski; Carrie E Bearden; Joseph F Cubells; Opal Y Ousley; Elaine F Walker; Tony J Simon; Joel Stoddard; Tara A Niendam; Marianne B M van den Bree; Doron Gothelf
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

2.  Neural and behavioral measures suggest that cognitive and affective functioning interactions mediate risk for psychosis-proneness symptoms in youth with chromosome 22q11.2 deletion syndrome.

Authors:  Samantha R Linton; Abbie M Popa; Steven J Luck; Khalima Bolden; Cameron S Carter; Tara A Niendam; Tony J Simon
Journal:  Am J Med Genet A       Date:  2020-04-22       Impact factor: 2.578

3.  Development of a computerised neurocognitive battery for children and adolescents with HIV in Botswana: study design and protocol for the Ntemoga study.

Authors:  J Cobb Scott; Amelia E Van Pelt; Allison M Port; Lucky Njokweni; Ruben C Gur; Tyler M Moore; Onkemetse Phoi; Ontibile Tshume; Mogomotsi Matshaba; Kosha Ruparel; Jennifer Chapman; Elizabeth D Lowenthal
Journal:  BMJ Open       Date:  2020-08-26       Impact factor: 2.692

Review 4.  Neurodevelopmental Trajectories and Psychiatric Morbidity: Lessons Learned From the 22q11.2 Deletion Syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Janneke Zinkstok; Danielle Baribeau; Samuel J R A Chawner; Jacob A S Vorstman
Journal:  Curr Psychiatry Rep       Date:  2021-02-24       Impact factor: 5.285

5.  Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome.

Authors:  Tyler M Moore; Deby Salzer; Doron Gothelf; Carrie E Bearden; Monica E Calkins; Wendy R Kates; Leila Kushan; Robert Sean Gallagher; Dafna Sofrin Frumer; Ronnie Weinberger; Donna M McDonald-McGinn; Raquel E Gur
Journal:  J Neurodev Disord       Date:  2021-06-14       Impact factor: 4.025

6.  Relationship between intelligence quotient measures and computerized neurocognitive performance in 22q11.2 deletion syndrome.

Authors:  Ruben C Gur; Tyler M Moore; Ronnie Weinberger; Ehud Mekori-Domachevsky; Raz Gross; Beverly S Emanuel; Elaine H Zackai; Edward Moss; Robert Sean Gallagher; Daniel E McGinn; Terrence Blaine Crowley; Donna McDonald-McGinn; Doron Gothelf; Raquel E Gur
Journal:  Brain Behav       Date:  2021-07-02       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.